Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Percutaneous Transluminal Coronary Angioplasty (PTCA) is a intervention that helps restore blood flow to the blocked coronary artery without the requirement of open-heart surgery. GlobalData uses proprietary data and analytics to provide a comprehensive report on the ptca balloon catheters devices market, including market shares of different players within Austria. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the ptca balloon catheters market in Austria was Boston Scientific followed by Shockwave Medical, Abbott Laboratories, Medtronic, Biotronik SE, Koninklijke Philips, Terumo, Microport Scientific, Meril Life Sciences, OrbusNeich and Teleflex.
In this intervention, a balloon at the end of a catheter is expanded to open the blocked coronary artery by compressing the plaque. Types of PTCA Balloon Catheters include PTCA Standard Balloon Catheters, Cutting and Scoring Balloon Catheters and PTCA Drug Coated Balloon (DCB) Catheters. Cutting and Scoring Balloon Catheters have microsurgical blades mounted longitudinally on the angioplasty balloon catheter. PTCA Standard Balloon Catheters are coronary catheters equipped with a balloon capable of expanding. A PTCA DCB Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries.
The value of the ptca balloon catheters devices market within Austria was expected to be over $6m in 2023.
For the latest complete market share analysis of ptca balloon catheters device market in Austria, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
